相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis
Sostenes Mistro et al.
CLINICAL INFECTIOUS DISEASES (2012)
Liposomal Amphotericin B for Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients: 2-Year Treatment Outcomes in Bihar, India
Prabhat K. Sinha et al.
CLINICAL INFECTIOUS DISEASES (2011)
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
Shyam Sundar et al.
LANCET (2011)
Ambisome plus miltefosine for Indian patients with kala-azar
Shyam Sundar et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2011)
Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India
Prabhat K. Sinha et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Increasing Incidence of Post-Kala-Azar Dermal Leishmaniasis in a Population-Based Study in Bangladesh
Kazi Mizanur Rahman et al.
CLINICAL INFECTIOUS DISEASES (2010)
Long-Term Intermittent Multiple Micronutrient Supplementation Enhances Hemoglobin and Micronutrient Status More Than Iron plus Folic Acid Supplementation in Bangladeshi Rural Adolescent Girls with Nutritional Anemia
Faruk Ahmed et al.
JOURNAL OF NUTRITION (2010)
Drug-Induced Nephrotoxicity Caused by Amphotericin B Lipid Complex and Liposomal Amphotericin B A Review and Meta-Analysis
Amar Safdar et al.
MEDICINE (2010)
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B Therapy
Smriti Mondal et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Enhanced Case Detection and Improved Diagnosis of PKDL in a Kala-azar-Endemic Area of Bangladesh
Dinesh Mondal et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
New treatment approach in Indian visceral leishmaniasis: Single-dose liposomal amphotericin B followed by short-course oral miltefosine
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2008)
The coexistence of other micronutrient deficiencies in anaemic adolescent schoolgirls in rural Bangladesh
F. Ahmed et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2008)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
Oliver A. Cornely et al.
CLINICAL INFECTIOUS DISEASES (2007)
Hypokalemic rhabdomyolysis in a child due to amphotericin B therapy
Paulo Sergio Lucas da Silva et al.
EUROPEAN JOURNAL OF PEDIATRICS (2007)
Liposomal amphotericin B for the treatment of visceral leishmaniasis
Caryn Bern et al.
CLINICAL INFECTIOUS DISEASES (2006)
Efficacy of liposomal amphotericin B (AmBisome®) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL)
AM Musa et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2005)
Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
DA Kafetzis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Amphotericin B treatment for Indian visceral leishmaniasis: Conventional versus lipid formulations
S Sundar et al.
CLINICAL INFECTIOUS DISEASES (2004)
Amphotericin B nephrotoxicity in children
RD Goldman et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: A multicenter study
S Sundar et al.
CLINICAL INFECTIOUS DISEASES (2003)
Mediterranean visceral leishmaniasis in HIV-negative adults: a retrospective analysis of 64 consecutive cases (1995-2001)
P Pagliano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: A multicenter study
S Sundar et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi:: Maximum tolerated dose study
TJ Walsh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial
S Sundar et al.
BRITISH MEDICAL JOURNAL (2001)
A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study
CP Thakur
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia
JR Wingard et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
